65 results
FWP
EVOK
Evoke Pharma Inc
3 Sep 13
Free writing prospectus
12:00am
and
future
sales
of
EVK-001
or
any
other
future
products
or
product
candidates.
By
their
nature,
forward-looking
statements
involve …
<10% dropouts, includes 5% due to
adverse events (AEs)
Majority of AEs were mild/moderate
and transient in nature
No significant cardiac changes
10-K
2013 FY
EX-10.13
EVOK
Evoke Pharma Inc
25 Mar 14
Annual report
12:00am
and specifications. All Alterations of whatever kind and nature shall become at once a part of the realty and shall be surrendered with the Premises upon expiration … cost and expense, all building permits and other permits of every kind and nature required by any governmental agency having jurisdiction in connection
10-K
2013 FY
EX-10.12
EVOK
Evoke Pharma Inc
25 Mar 14
Annual report
12:00am
of any nature pertaining to SynteractHCR’s provision of Services hereunder and/or pertaining to any Confidential Information (as defined below
D
EVOK
Evoke Pharma Inc
30 Jun 10
$6M in equity, sold $6M, 20 investors
12:00am
in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under
8-K
sgo2lz2eran
30 Nov 22
Other Events
10:07am
8-K
tmiasm88rd98 9zru5m
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-3.1
v8lw5
30 Sep 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
EX-10.2
u9o75x65las7pgdv5ks9
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-10.1
asagyvnf
28 May 14
Entry into a Material Definitive Agreement
12:00am
10-K
vevfqt
25 Mar 14
Annual report
12:00am